Literature DB >> 28785459

Chagas Heart Failure in Patients from Latin America.

Reinaldo B Bestetti1.   

Abstract

Physicians working in Europe and the United States should suspect Chagas heart failure in every patient coming from Latin America with chronic heart failure. Diagnosis should be confirmed by positive serology. Right bundle branch block and left anterior fascicular block on 12-lead electrocardiogram, enlarged cardiac silhouette with no pulmonary congestion on chest X-ray and left ventricular apical aneurysm on echocardiography are the distinctive features of this condition. The clinical course is poorer than that of non-Chagas heart failure; however, medical treatment is similar. Implantable cardioverter-defibrillators are useful in the primary and secondary prevention of sudden cardiac death. Cardiac resynchronisation therapy can be given to patients on optimal medical therapy and with lengthened QRS complex. Heart transplantation is the treatment of choice for patients with end-stage Chagas heart failure.

Entities:  

Keywords:  Chagas disease; heart failure; heart transplantation; implantable cardioverter-defibrillator; sudden cardiac death

Year:  2016        PMID： 28785459      PMCID： PMC5490952          DOI： 10.15420/cfr.2016:14:2

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN： 2057-7540


  60 in total

1.  Automatic implantable cardioverter-defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias.

Authors:  Augusto Cardinalli-Neto; Osvaldo T Greco; Reinaldo B Bestetti
Journal:  Pacing Clin Electrophysiol       Date:  2006-05       Impact factor: 1.976

2.  Asymptomatic coronary artery disease in chagasic patients with heart failure: prevalence and risk factors .

Authors:  Gustavo Carvalho; Salvador Rassi; José Maria Dias de Azeredo Bastos; Sílvio Sérgio Pontes Câmara
Journal:  Arq Bras Cardiol       Date:  2011-10-21       Impact factor: 2.000

3.  Mychophenolate mofetil increased chagas disease reactivation in heart transplanted patients: comparison between two different protocols.

Authors:  Fernando Bacal; Christiano Pereira Silva; Edimar Alcides Bocchi; Philippe Vieira Pires; Luiz Felipe P Moreira; Victor Sarli Issa; Silvia Ayub Moreira; Fátima das Dores Cruz; Tânia Strabelli; Noedir Antonio Groppo Stolf; José Antonio Franchini Ramires
Journal:  Am J Transplant       Date:  2005-08       Impact factor: 8.086

Review 4.  Chagas disease and stroke.

Authors:  Francisco Javier Carod-Artal; Joaquim Gascon
Journal:  Lancet Neurol       Date:  2010-05       Impact factor: 44.182

5.  Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease.

Authors:  J Samuel; M Oliveira; R R Correa De Araujo; M A Navarro; G Muccillo
Journal:  Am J Cardiol       Date:  1983-07       Impact factor: 2.778

6.  Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors.

Authors:  Ester C Sabino; Antonio L Ribeiro; Vera M C Salemi; Claudia Di Lorenzo Oliveira; Andre P Antunes; Marcia M Menezes; Barbara M Ianni; Luciano Nastari; Fabio Fernandes; Giuseppina M Patavino; Vandana Sachdev; Ligia Capuani; Cesar de Almeida-Neto; Danielle M Carrick; David Wright; Katherine Kavounis; Thelma T Goncalez; Anna Barbara Carneiro-Proietti; Brian Custer; Michael P Busch; Edward L Murphy
Journal:  Circulation       Date:  2013-02-07       Impact factor: 29.690

7.  Global economic burden of Chagas disease: a computational simulation model.

Authors:  Bruce Y Lee; Kristina M Bacon; Maria Elena Bottazzi; Peter J Hotez
Journal:  Lancet Infect Dis       Date:  2013-02-08       Impact factor: 25.071

8.  Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.

Authors:  Augusto Cardinalli-Neto; Reinaldo B Bestetti; José A Cordeiro; Vanessa C Rodrigues
Journal:  J Cardiovasc Electrophysiol       Date:  2007-09-26

9.  Chagas' cardiomyopathy: the economic burden of an expensive and neglected disease.

Authors:  Abrão Abuhab; Evelinda Trindade; Gabriel Barros Aulicino; Sandra Fujii; Edimar Alcides Bocchi; Fernando Bacal
Journal:  Int J Cardiol       Date:  2013-03-05       Impact factor: 4.164

10.  Heart transplantation for Chagas cardiomyopathy in the United States.

Authors:  E P Kransdorf; L S C Czer; D J Luthringer; J K Patel; S P Montgomery; A Velleca; J Mirocha; P C Zakowski; R Zabner; C R Gaultier; Y Qvarnstrom; T Benedict; F Steurer; E Bosserman; C D Paddock; M Rafiei; J A Kobashigawa
Journal:  Am J Transplant       Date:  2013-10-28       Impact factor: 8.086
View more
  6 in total

1.  The Indeterminate Form of Chagas Disease.

Authors:  Victor Sarli Issa
Journal:  Arq Bras Cardiol       Date:  2018-02       Impact factor: 2.000

2.  Prevalence of Chagas disease in Colombia: A systematic review and meta-analysis.

Authors:  Mario J Olivera; Johana A Fory; Julián F Porras; Giancarlo Buitrago
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

3.  Undernutrition and Cachexia in Patients with Decompensated Heart Failure and Chagas Cardiomyopathy: Occurrence and Association with Hospital Outcomes.

Authors:  Larissa Candido Alves Tavares; Silvia Helena Gelás Lage; Edimar Alcides Bocchi; Victor Sarli Issa
Journal:  Arq Bras Cardiol       Date:  2022-01       Impact factor: 2.000

4.  Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy.

Authors:  Sergio Alejandro Gómez-Ochoa; Paula Katherine Bautista-Niño; Lyda Z Rojas; Lukas Hunziker; Taulant Muka; Luis E Echeverría
Journal:  Front Cell Infect Microbiol       Date:  2022-08-08       Impact factor: 6.073

Review 5.  Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis.

Authors:  Lyda Z Rojas; Marija Glisic; Laura Pletsch-Borba; Luis E Echeverría; Wichor M Bramer; Arjola Bano; Najada Stringa; Asija Zaciragic; Bledar Kraja; Eralda Asllanaj; Rajiv Chowdhury; Carlos A Morillo; Oscar L Rueda-Ochoa; Oscar H Franco; Taulant Muka
Journal:  PLoS Negl Trop Dis       Date:  2018-06-13

6.  Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole.

Authors:  Claudia Magalhães Calvet; Tatiana Araújo Silva; Diane Thomas; Brian Suzuki; Ken Hirata; Jair Lage Siqueira-Neto; James H McKerrow
Journal:  PLoS Negl Trop Dis       Date:  2020-09-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.